Humera Khurshid

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Neoadjuvant Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Radiation for Rectal Cancer

T.A. DiPetrillo, Victor E. Pricolo, Jorge A. Lagares-García et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 99 citations · Full text

Medicine, Oncology, Radiation Oncology +14

NSCLC: An Update of Driver Mutations, Their Role in Pathogenesis and Clinical Significance.

Robert C. Black, Humera Khurshid · PubMed · 2015 · 52 citations

Medicine, Molecular Genetics, Oncology +17

Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study

Jaroslaw T. Hepel, K.L. Leonard, Howard Safran et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 52 citations

Medicine, Oncology, Radiation Oncology +16

Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study

Andrew Schumacher, William M. Sikov, Matthew I. Quesenberry et al. · PLoS ONE · 2017 · 48 citations · Full text

Medicine, Oncology, Evidence-based Practice +13